Stockreport

Ocular Therapeutix Says FDA Talks Progressing as It Eyes AXPAXLI NDA for Wet AMD on SOL-1 Data [Yahoo! Finance]

Ocular Therapeutix, Inc.  (OCUL) 
Last ocular therapeutix, inc. earnings: 3/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ocutx.com
PDF pursuing an NDA for AXPAXLI in wet AMD based on a single, well-powered pivotal study — the company says regulators have signaled openness to single-trial approvals when [Read more]